Mathew D Littlejohn

Summary

Publications

  1. ncbi Ile164 variant of beta2-adrenoceptor does not influence outcome in heart failure but may interact with beta blocker treatment
    Mathew D Littlejohn
    Department of Pathology and Carney Centre for Pharmacogenomics, University of Otago, Christchurch, PO Box 4345, Christchurch, New Zealand
    Eur J Heart Fail 10:55-9. 2008

Detail Information

Publications1

  1. ncbi Ile164 variant of beta2-adrenoceptor does not influence outcome in heart failure but may interact with beta blocker treatment
    Mathew D Littlejohn
    Department of Pathology and Carney Centre for Pharmacogenomics, University of Otago, Christchurch, PO Box 4345, Christchurch, New Zealand
    Eur J Heart Fail 10:55-9. 2008
    ..The Ile164 variant of the beta2-adrenoceptor has been shown to alter cardiovascular phenotypes and adversely affect survival in heart failure patients...